title: [Sparfloxacin (Sparflo) in the treatment of urological infections].
abstract: Sparfloxacin efficacy evaluation for the treatment of urogenital tract infections is presented. The trial was performed on 43 patients with chronic complicated infections of urogenital tract (pyelonephritis, prostatitis). Sparfloxacin (once daily for 7-14 days) was highly effective in the infection management according to clinical and bacteriological results (83.7 per cent and 78.1 per cent subsequently).
authors.forename: N A
authors.initials: NA
authors.lastname: Lopatkin
authors.forename: I I
authors.initials: II
authors.lastname: Derevianko
authors.forename: L N
authors.initials: LN
authors.lastname: Lavrinova
authors.forename: L A
authors.initials: LA
authors.lastname: Nefedova
mesh_terms: D000890:Anti-Infective Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D024841:Fluoroquinolones; D006801:Humans; D008297:Male; D011472:Prostatitis / Q000188:drug therapy*; D011704:Pyelonephritis / Q000188:drug therapy*
chemical_list: D000890:Anti-Infective Agents; D024841:Fluoroquinolones; C061363:sparfloxacin